Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Development deals
Biotech
Candid unwraps 3 collabs to develop new T-cell engagers
Candid will partner with EpimAb Biotherapeutics, Nona Biosciences and Ab Studio to beef up its pipeline of bispecific antibodies.
Darren Incorvaia
Dec 16, 2024 11:59am
Genmab buys 2nd antibody from Scancell in deal worth up to $630M
Dec 4, 2024 11:55am
GSK offers Rgenta up to $500M biobucks per target in RNA deal
Dec 4, 2024 8:00am
Gilead advances ADC dreams with potential $465M deal
Dec 3, 2024 10:54am
Cour inks $940M-plus autoimmune deal with Roche's Genentech
Dec 3, 2024 7:58am
Spanish gene editor licenses DNA-cutting enzymes for up to $43M
Nov 4, 2024 1:46pm
